Goldman Sachs upgraded CVS Caremark (NYSE: CVS) from Neutral to Buy with a price target of $113.00 (from $95.00).Analyst Robert ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE